Related Experiment Video
Updated: Jan 15, 2026
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Cardiorespiratory benefits of reducing indoor particulate matter depend on immune improvements: Insights into
Aojing Han1, Wenlou Zhang2, Luyi Li1
1Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.
Abstract:
Indoor air pollution and health have emerged as a significant environmental and public health concern globally. However, individual heterogeneity in immune response to indoor particulate matter (PM) reduction and its role in cardiorespiratory benefits remain unclear. This randomized, double-blind crossover trial was performed among 80 healthy college students in Beijing, China, including two 4-day indoor air purification sessions (real and sham), separated by a 16-day washout period. Real-time indoor PM levels were monitored. Nasal mucosal lining fluid was collected one day before cardiorespiratory assessments and fasting blood collection to detect immune molecules. Linear mixed-effect models were used to estimate intervention effects. We found reducing indoor PM significantly improved nasal and systemic immunity, but not overall cardiorespiratory function. Further individual-level analysis revealed heterogeneous changes in immune and cardiorespiratory indicators. Specifically, respiratory benefits occurred in individuals with greater nasal immunity improvements, while cardiovascular benefits primarily depended on improvements in systemic immunity. Both respiratory and cardiovascular benefits were observed in individuals with improvements in both nasal and systemic immunity. Notably, even when indoor PM concentrations were below WHO air quality guidelines, further reducing PM exposure still yielded immune improvements. These findings support precision interventions in indoor PM pollution tailored to individual immune sensitivity.
Related Concept Videos
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:23Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...